Category: Oncology/Hematology
Global Oncology/Hematology
-
Global Neoantigen Cancer Vaccine Market Report and Forecast 2023-2031
... for effective and personalized treatment across the globe. The market size is anticipated to grow at a CAGR of 69.4% during the forecast period of 2023-2031 to achieve a value of USD 8872.5 million by ... Read More
-
Global Blood Cancer Molecular Diagnostics Supply, Demand and Key Producers, 2023-2029
... during the forecast period (2023-2029). This report studies the global Blood Cancer Molecular Diagnostics demand, key companies, and key regions. This report is a detailed and comprehensive analysis of the world market for Blood Cancer ... Read More
-
Global Blood Cancer Molecular Diagnostics Market 2023 by Company, Regions, Type and Application, Forecast to 2029
... USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while ... Read More
-
Microcatheters Market by Type (Delivery, Diagnostic, Aspiration, Steerable), Design (Single, Dual), Application (Cardiovascular, Neurovascular, Peripheral Vascular, Oncology), End-User (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2028
... USD 1,142 million by 2028 from USD 874 million in 2023, growing at a CAGR of 5.5% during the forecast period. The rise in advantages offered by microcatheter like Minimally Invasive, precise navigation, and targeted ... Read More
-
Global Hodgkin’s Lymphoma Market - 2023-2030
... Hodgkin’s lymphoma market is expected to exhibit a CAGR of 9.8% during the forecast period (2023-2030). The increasing technological advancements and the growing investments in novel products are driving up demand for Hodgkin’s lymphoma market ... Read More
-
Global Non-Hodgkin Lymphoma Market - 2023-2030
... non-Hodgkin lymphoma market is expected to exhibit a CAGR of 8.2% during the forecast period (2023-2030). The NHL market has witnessed a notable emphasis on the development and commercialization of targeted therapies. Biomarker identification and ... Read More
-
Global Breast Cancer Drugs Market Market - 2023-2030
... 2030. The Global Breast Cancer Drugs Market is expected to exhibit a CAGR of 9.2% during the forecast period 2023-2030. The increasing demand for discovering novel therapies and optimizing existing treatments are driving up demand ... Read More
-
Global Bone Cancer Market - 2023-2030
... Bone Cancer Market is expected to exhibit a CAGR of 4.8% during the forecast period 2023-2030. Bone cancer can begin in any bone in the body, but it most commonly affects the pelvis or the ... Read More
-
Natural Killer Cells Therapeutics Market by Therapeutics (NK Cell Therapies and NK Cell Directed Antibodies), Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, and Others), and End User (Research Centers & Institutes, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2027
... Analysis and Industry Forecast, 2027 The Natural Killer (NK) Cells Therapeutics market refers to the pharmaceutical products and therapies aimed at utilizing and enhancing the functions of natural killer cells for therapeutic purposes. Natural killer ... Read More
-
Oncology Biosimilars Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 14.7 Billion by 2028, exhibiting a growth rate (CAGR) of 21.6% during 2023-2028. Cancer is a lifestyle disease that occurs due to the abnormal growth of cells and may result in the formation ... Read More
-
Bronopol Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... US$ 1.5 Billion by 2028, exhibiting a growth rate (CAGR) of 4.8% during 2023-2028. Bronopol is a colorless, water-soluble organic compound, produced by the bromination of di(hydroxymethyl)-nitromethane. It is supplied as crystals or crystalline powder, ... Read More
-
Global Oncology Radiopharmaceutical Supply, Demand and Key Producers, 2023-2029
... (2023-2029). This report studies the global Oncology Radiopharmaceutical production, demand, key manufacturers, and key regions. This report is a detailed and comprehensive analysis of the world market for Oncology Radiopharmaceutical, and provides market size (US$ ... Read More
-
Global Oncology Radiopharmaceutical Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
... and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. This ... Read More
-
2023 Global Forecast for Pet Cancer Therapeutics Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Global Cancer Biologics Market Size study & Forecast, by Product (Monoclonal Antibodies, Cytokine-Based Immunotherapy, Cancer Vaccines, CAR-T Cell Therapy, and Immune Checkpoint Inhibitors), by Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Others), by Distribution Channel (Hospitals, Clinics, and Others) and Regional Analysis, 2023-2030
... Leukemia, Lymphoma, Others), by Distribution Channel (Hospitals, Clinics, and Others) and Regional Analysis, 2023-2030 Global Cancer Biologics Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy ... Read More
-
Global Colorectal Cancer (CRC) Screening Market (2023 Edition): Analysis by Screening Type, End-Use, By Region, By Country: Market Insights and Forecast (2019-2029)
... Screening Market (2023 Edition)” which provides a complete analysis of the global Colorectal Cancer (CRC) Screening industry in terms of segmentation by Screening Type (Stool-based Tests, Flexible Sigmoidoscopy, Colonoscopy, CT Colonography - Virtual Colonoscopy, Other ... Read More
-
2023 Global Forecast for Peptide Cancer Vaccine Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Fc Fusion Therapeutics Market, 2021-2030 Distribution by Target Indications (Neutropenia, Graft Versus Host Disease, Breast Cancer, Rheumatoid Arthritis, Non-Small Cell Lung Cancer, Neovascular (Wet) Age-related Macular Degeneration (AMD), Hemophilia A, Neuromyelitis Optica Spectrum Disorders and Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2021-2030
... Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): ... Read More
-
Near-infrared Imaging Market by Product (Imaging System, Probe, Dye (Organic, Nanoparticle)), Procedure (Cancer, CVD, GI, OB/GYN), Application (Preclinical, Clinical, Medical), End User (Hospital, Pharma, Research Lab) & Region - Global Forecast to 2028
... near infrared imaging market is projected to reach USD 1.9 billion by 2028 from USD 1.0 billion in 2023, at a CAGR of 14.0% from 2023 to 2028. Factors such as the high incidence/prevalence of ... Read More
-
Global Orphan Drugs Market Size study & Forecast, by Drug Type (Biological, Non-biological) by Top Selling Drugs (Revlimid, Darzalex, Rituxan, Tafinlar, Ninlaro, Other), by Disease Type (Oncology, Hematology, Neurology, Cardiovascular, Other Disease Types) and Regional Analysis, 2023-2030
... Analysis, 2023-2030 Global Orphan Drugs Market is valued approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Orphan drugs, ... Read More
-
Global Fiducial Markers Market Size study & Forecast, by Product (Metal Based Markers, Polymer Based Markers, Other Fiducial Markers) by Modality (CT/CBCT, MRI, Radiotherapy, Ultrasound), by Cancer type (Lung Cancer, Breast Cancer, Gastric Cancer, Prostate Cancer, Other Cancers), by End User (Hospitals and Outpatient Facilities, Cancer Research Centers, Independent Radiotherapy Centers) and Regional Analysis, 2023-2030
... Cancer, Other Cancers), by End User (Hospitals and Outpatient Facilities, Cancer Research Centers, Independent Radiotherapy Centers) and Regional Analysis, 2023-2030 Global Fiducial Markers Market is valued approximately at USD XX billion in 2022 and is ... Read More
-
Global Hepatocellular Carcinoma Market - 2023-2030
... the forecast period 2023-2030. The hepatocellular carcinoma market trends show a large pipeline for hepatocellular carcinoma owing to the rising clinical trials and increasing research and development. The hepatocellular carcinoma (HCC) market of intrahepatic bile ... Read More
-
Global Prostate Cancer Market - 2023-2030
... is expected to exhibit a CAGR of 8.1% from 2023 to 2030. Prostate cancer is the second-most typical cancer arising in males, behind skin cancer. The growing prevalence of prostate cancer, raising awareness concerning early ... Read More
-
Global Gall Bladder Cancer Treatment Market - 2023-2030
... 2030. The Global Gall Bladder Cancer Treatment Market is exhibiting at a CAGR of 5.5% during the forecast period 2023-2030. The Gall Bladder Cancer Treatment Market is a segment of the overall oncology therapeutics market, ... Read More
-
Global Endometrial Cancer Market - 2023-2030
... endometrial cancer market is expected to exhibit a CAGR of 4.9% during the forecast period (2023-2030). The key market players in this market include Pfizer, AbilityPharma (Ability Pharmaceuticals, SL), and GlaxoSmithKline among others. Market Dynamics ... Read More
Research Assistance
